TCF — Theracryf Balance Sheet
0.000.00%
- £3.53m
- £1.52m
- £0.40m
Annual balance sheet for Theracryf, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.13 | 11.6 | 9.03 | 5 | 2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.531 | 0.652 | 0.483 | 1.02 | 0.972 |
Prepaid Expenses | |||||
Total Current Assets | 4.77 | 12.3 | 9.58 | 6.13 | 3.03 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0.005 | 0.005 | 0.003 | 0.001 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 4.86 | 12.4 | 9.64 | 6.17 | 3.06 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.653 | 0.607 | 0.411 | 0.833 | 0.723 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.653 | 0.607 | 0.411 | 0.833 | 0.721 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 4.2 | 11.8 | 9.23 | 5.34 | 2.34 |
Total Liabilities & Shareholders' Equity | 4.86 | 12.4 | 9.64 | 6.17 | 3.06 |
Total Common Shares Outstanding |